Why Delayed-Release Capsules?
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from human gastric juice with a remarkable ability to accelerate healing in the gastrointestinal tract. The challenge is getting it there. Standard capsules dissolve rapidly in stomach acid, releasing the peptide before it can reach the lower GI tract where it's most needed.
Surviving the Stomach's Acid Environment
Delayed-release (enteric-coated) capsules use a specialized polymer shell that remains intact in the low-pH environment of the stomach (pH 1–3) but dissolves once it reaches the small intestine (pH 6–7). This allows a full, bioavailable dose of BPC-157 to reach the duodenum, jejunum, and colon — the exact sites where conditions like leaky gut, Crohn's disease, and IBS manifest.
Conditions That Benefit Most
- Leaky gut syndrome (intestinal permeability)
- Irritable Bowel Syndrome (IBS)
- Inflammatory Bowel Disease (IBD)
- Post-antibiotic gut dysbiosis
- Small intestinal inflammation
- Ulcers and gastric mucosal damage
The Research Behind BPC-157 & the Gut
BPC-157 has been shown in preclinical research to upregulate growth hormone receptors, stimulate angiogenesis (new blood vessel formation) in the gut lining, and modulate the nitric oxide (NO) system — all of which are critical pathways for healing damaged intestinal tissue. It also exhibits protective effects against NSAIDs, alcohol, and stress-induced gut injury.
Infiniwell uses pharmaceutical-grade manufacturing standards (GMP-certified) and formats their BPC-157 Delayed Pro specifically for lower GI delivery. This is the exact formulation Dr. Bell recommends for his gut health patients.